期刊文献+

超声监测排卵的临床应用及价值评定 被引量:1

Evaluation on Clinical Application and Value of Ultrasonic Monitoring of Ovulation
下载PDF
导出
摘要 目的探讨选择超声技术对排卵进行监测的临床应用价值。方法随机选择该院2014年4月—2016年7月收治的因为排卵障碍造成不孕症的患者190例作为研究对象;临床在选择克罗米芬药物实施促排卵治疗过程中,配合对患者实施超声检查。在患者月经开始后的第10天,对患者卵泡发育情况以及患者子宫内膜增殖厚度进行仔细监测,对所有患者卵泡数目、卵泡大小以及卵泡形态等加以认真观察,明确患者是否表现出排卵破裂的现象。结果临床对所有不孕症患者实施排卵治疗后,其中表现出卵泡发育成熟的患者145例,所占比例为76.32%;表现出卵泡发育不成熟的患者15例,所占比例为7.89%;表现出未破裂卵泡黄素化综合征的患者23例,所占比例为12.11%;表现出卵巢过度刺激综合征的患者7例,所占比例为3.68%。结论对于因为排卵障碍造成不孕症的患者,选择超声技术对患者的排卵情况进行监测,针对患者临床用药以及患者性生活进行有效指导,针对不孕症的临床治疗发挥显著效果。 Objective To discuss the clinical application and value of ultrasonic monitoring of ovulation. Methods 190 cases of patients with barrenness due to the ovulation disorder admitted and treated in our hospital from April 2014 to July2016 were random selected as the research objects and the patients were given the ultrasonic monitoring in the course of promoting ovulation by the clomiphene, and the foliiculi developmental condition and endometrium hyperplasia thickness of patients were carefully monitored, and the foliiculi number, size and shape were carefully observed, and the ovulation rupture of patients was cleared. Results In clinic, after the ovulation treatment, 145 cases of patients showed the mature foliiculi development, accounting for 76.32%, and 15 cases showed the immature foliiculi development, accounting for 7.89%,and 23 cases showed lutenized unruptured, accounting for 12.11% and 7 cases showed ovarian hyperstimulation syndrome,accounting for 3.68%. Conclusion We should select the ultrasonic technique in monitoring the ovulation condition of patients with barrenness due to the ovulation disorder and effectively guide the clinical medication of patients and sexual life thus playing a significant effect in the clinical treatment of barrenness.
作者 赵晓洁
出处 《中外医疗》 2017年第5期166-168,共3页 China & Foreign Medical Treatment
关键词 超声监测 排卵 临床应用 Ultrasonic Ovulation Clinical application
  • 相关文献

参考文献10

二级参考文献85

  • 1谢红宁.妇产科超声诊断学[M].北京:人民卫生出版社,2006.91,93,107,125,143.
  • 2王纯正,徐智章.超声诊断学[M].2版.北京:人民卫生出版社,2006:145.
  • 3乐杰.妇产科学[M]5版[M].北京:人民卫生出版社,2001.129.
  • 4罗丽兰.不孕与不育[M].北京:人民卫生出版社,2005:39,202.
  • 5乐杰.妇产科学[M].第6版.北京:人民卫生出版社,2007,275.
  • 6吴钟瑜.实用妇产科超声诊断学[M].3版.天津:天津科技翻译出版公司,2000-1-1.
  • 7Mo Y,,Peng P,Zhou R,et al.Regulation of gonadotropin-releasing hormone(GnRH)receptor-I expression in the pituitary and ovary by a GnRH agonist and antagonist. Reprod Sci . 2010
  • 8Hirata JD,Moghissi KS,Ginsburg KA.Pregnancy after medical therapy of adenomyosis with a gonadotropin-releasing hormone agonist. Fertility and Sterility . 1993
  • 9Silva,PD,Perkins,HE,Schauberger,CW.Live birth after treatment of severe adenomyosis with a gonadotropin-releasing hormone agonist. Fertility and Sterility . 1994
  • 10周永昌;郭万学.超声医学[M]北京:科学技术文献出版社,19981172-1174.

共引文献29

同被引文献18

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部